^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

CD163 overexpression

i
Other names: CD163, CD163 Molecule, M130, Scavenger Receptor Cysteine-Rich Type 1 Protein M130, Hemoglobin Scavenger Receptor, CD163 Antigen, SCARI1, MM130, Macrophage-Associated Antigen
Entrez ID:
Related biomarkers:
3ms
Niosomal hesperidin attenuates the M1/M2-macrophage polarization-based hepatotoxicity followed chlorpyrifos -induced toxicities in mice. (PubMed, Pestic Biochem Physiol)
The ameliorative effects of Hesp and Nio + Hesp may be at least in part due to their antioxidant and anti-inflammatory properties. These findings showed that both M1- and M2-macrophages contributed to the development of hepatic lesions induced by CPF and provided information about macrophage activation, indicating the importance of analysis of macrophage phenotypes for hepatotoxicity based on M1/M2-polarization which can be downregulated by niosomal nesperidin.
Preclinical • Journal
|
CD163 (CD163 Molecule) • CD68 (CD68 Molecule)
|
CD163 overexpression • CD163 expression
2years
Identification of six hub genes and analysis of their correlation with drug sensitivity in acute myeloid leukemia through bioinformatics. (PubMed, Transl Cancer Res)
However, sensitivity to Erlotinib was correlated with high expression of PF4 and PPBP. In summary, FLT3, PF4, CD163, MRC1, CSF2RB, PPBP may be potential biomarkers and potential sensitive small-molecule drugs were correlated with overexpression of the biomarkers in AML.
Journal
|
FLT3 (Fms-related tyrosine kinase 3) • CD163 (CD163 Molecule) • MRC1 (Mannose Receptor C-Type 1)
|
CD163 overexpression • FLT3 overexpression • CD163 expression
|
erlotinib
almost3years
[VIRTUAL] Exploiting Cholesterol Metabolism to Treat Primary and Metastatic Renal Carcinoma (KCRS 2021)
Moreover, pharmacological inhibition of SCARB1 using a novel compound (ITX-5061) results in decreased ccRCC cell proliferation in vitro...The impact of this KCRP Idea Development Application comes from the pressing need for new therapeutic strategies, given that targeted therapies, anti-angiogenics, immunotherapies, and other metabolic strategies (such as targeting glutamine metabolism) only serve subsets of patients, even in combination, and altered cholesterol metabolism is a universal feature of ccRCC. Finally, as HIF-2alpha antagonists continue to be tested in ongoing clinical trials, SCARB1 inhibition could be deployed in patients ultimately acquiring resistance to HIF-2alpha-specific drugs, as previously demonstrated in preclinical studies.
IO biomarker
|
EPAS1 (Endothelial PAS domain protein 1)
|
CD163 overexpression
over3years
Effect of macrophages on biological function of ovarian cancer cells in tumor microenvironment in vitro. (PubMed, Arch Gynecol Obstet)
In the simulated in vitro tumor microenvironment, co-cultured ovarian cancer cells polarized macrophages to the M2 phenotype. Furthermore, M2 macrophages enhanced the proliferation, invasion and migration, and inhibited the apoptosis of ovarian cancer cells.
Journal
|
CD163 (CD163 Molecule)
|
CD163 overexpression